- Home
- WWR vs EDSA Comparison
WWR vs EDSA Comparison
Compare WWR & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWR | EDSA |
|---|---|---|
| Founded | 1977 | 2015 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.8M | 51.6M |
| IPO Year | 2006 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WWR | EDSA |
|---|---|---|
| Price | $0.41 | $5.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.92 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 627.2K | 59.1K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.38 | $0.72 |
| 52 Week High | $3.75 | $20.32 |
Technical Indicators
Market Signals| Indicator | WWR | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 37.82 | 33.28 |
| Support Level | N/A | $4.87 |
| Resistance Level | $0.45 | $9.00 |
| Average True Range (ATR) | 0.02 | 0.57 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 42.09 | 15.07 |
Price Performance
Historical ComparisonAbout WWR Westwater Resources Inc.
Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.